A health technology assessment of transient elastography in adult liver disease

Canadian Journal of Gastroenterology

Volumn 27, Issue 3, 2013, Pages 149-158

  Steadman, Rodney ^a   Myers, Robert P ^b   Leggett, Laura ^a   Lorenzetti, Diane ^a   Noseworthy, Tom ^a   Rose, Sarah ^a   Sutherland, Lloyd ^a   Clement, Fiona ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Health technology assessment; Liver biopsy; Liver disease; Transient elastography

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CHOLESTATIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ELASTOGRAPHY; HEPATITIS B; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRANSIENT ELASTOGRAPHY; CHOLESTASIS; COMPLICATION; ECHOGRAPHY; LIVER; PATHOLOGY;

CHOLESTASIS; ELASTICITY IMAGING TECHNIQUES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; SENSITIVITY AND SPECIFICITY; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84876260360     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/684982     Document Type: Review

References (78)

1. Wilbur K, Sidhu K. Beta blocker prophylaxis for patients with variceal hemorrhage. J Clin Gastroenterol 2005;39:435-40.
2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18.
3. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications. Gut 2004;53:744-9.
4. Griffiths C, Rooney C, Brock A. Leading causes of death in England and Wales - how should we group causes? Health Stat Quart 2005;28:6-17.
5. Statistics Canada. Age-standardized mortality rates by selected causes, by sex. (Accessed October 18, 2011).
6. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14.
7. Murtagh J, Foerster V. Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis. Issues Emerg Health Technol 2006;90:1-4.
8. Whiting P, Rutjes WA, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:1-13.
9. Dwamena BA. Statistical software components. Boston: Boston College Department of Economics; 2007.
10. Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. JCE 2005;58:982-90.
11. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med 2002;21:1539-58.
12. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
13. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: Meta-analysis in Context, 2nd edn. London: BMJ Books; 2001.
14. Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies, 3rd edn. Ottawa: 2006.
15. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: A systematic review of diagnostic test accuracy. Am J Gastroenterol 2007;102:2589-600.
16. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 2008;134:960-74.
17. Stebbing J, Farouk L, Panos G, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010;44:214-9.
18. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. J Hepatol 2011;54:650-9.
19. Adelaide Health Technology Assessment on behalf of National Horizon Scanning Unit (HealthPACT and MSAC). MR and transient elastography for the non-invasive assessment of liver fibrosis; horizon scanning prioritising summary, vol 14; 2006.
20. Haute Autorite de Sante/French National Authority for Health. Assessment of non-invasive techniques to measure liver fibrosis in chronic viral hepatitis C and B. Health Technology Assessment Database 2007.
21. National Horizon Scanning Centre. Enhanced liver fibrosis test (ELF) for evaluating liver fibrosis. Birmingham: University of Birmingham, 2008.
22. CADTH. Transient elastography for evaluation of liver fibrosis: Guidelines and clinical and cost effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2008.
23. Alric L, Kamar N, Bonnet D, et al. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidneytransplant patients with chronic viral hepatitis. Transplant Int 2009;22:568-73.
24. Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R. Noninvasive markers of fibrosis and inflammation in clinical practice: Prospective comparison with liver biopsy. Eur J Gastroenterol Hepatol 2010;22:474-80.
25. Arena U, Vizzutti F, Abraldes JG, et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008;57:1288-93.
26. Berzigotti A, Abraldes JG, Tandon P, et al. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J Hepatol 2010;52:846-53.
27. Bonnard P, Sombie R, Lescure F, et al. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 2010;82:454-8.
28. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplantation 2006;12:1791-8.
29. Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferasebased algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009;16:36-44.
30. Chang PE, Lui HF, Chau YP, et al. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: Comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Pharmacol Ther 2008;28:51-61.
31. Cho HJ, Seo YS, Lee KG, et al. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients. J Gastroenterol Hepatol 2011;26:492-500.
32. Coco B, Oliveri F, Maina AM, et al. Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360-9.
33. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005;42:838-45.
34. Corpechot C, El NA, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006;43:1118-24.
35. Corradi F, Piscaglia F, Flori S, et al. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: Usefulness of transient elastography. Dig Liv Dis 2009;41:217-25.
36. Cross TJS, Calvaruso V, Maimone S, et al. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat 2010;17:546-54.
37. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol 2010;53:1013-21.
38. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut 2006;55:403-8.
39. Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: Noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009;252:595-604.
40. Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011;54:64-71.
41. Ganne-Carrie N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-7.
42. Gomez-Dominguez E, Mendoza J, Garcia-Buey L, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther 2008;27:441-7.
43. Harada N, Soejima Y, Taketomi A, et al. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation 2008;85:69-74.
44. Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, Stärkel P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: A real-life study. J Clin Gastroenterol 2010;44:575-82.
45. Kamphues C, Lotz K, Rocken C, et al. Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients. Clin Transplant 2010;24:652-9.
46. Kanamoto M, Shimada M, Ikegami T, et al. Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg 2009;16:463-7.
47. Kim KM, Choi WB, Park SH, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: A prospective study of living related potential liver donors. J Gastroenterol 2007;42:382-8.
48. Kim dY, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009;54:1758-63.
49. Kim SU, Ahn SH, Park JY, et al. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol 2009;43:267-71.
50. Kirk GD, Astemborski J, Mehta SH, et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009;48:963-72.
51. Koizumi Y, Hirooka M, Kisaka Y, et al. Liver fibrosis in patients with chronic hepatitis C: Noninvasive diagnosis by means of realtime tissue elastography - establishment of the method for measurement. Radiology 2011;258:610-7.
52. deLedinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006;41:175-9.
53. Lee MH, Cheong JY, Um SH, et al. Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci 2010;55:3552-60.
54. Liu CH, Liang CC, Huang KW, et al. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol 2011;6:1057-65.
55. Lupsor M, Badea R, Stefanescu H, et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointest Liv Dis 2010;19:53-60.
56. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liv Int 2009;29:242-7.
57. Masuzaki R, Tateishi R, Yoshida H, et al. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol 2008;22:753-7.
58. Miailhes P, Pradat P, Chevallier M, et al. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients. J Viral Hepat 2011;18:61-9.
59. Moessner BK, Jorgensen TR, Skamling M, et al. Outreach screening of drug users for cirrhosis with transient elastography. Addiction 2010;106:970-6.
60. Mueller S, Millonig G, Sarovska L, et al. Increased liver stiffness in alcoholic liver disease: Differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010;16:966-72.
61. Myers RP, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G. Transient elastography for the noninvasive assessment of liver fibrosis: A multicentre Canadian study. Can J Gastroenterol 2010;24:661-70.
62. Nahon P, Kettaneh A, Tengher-Barna I, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008;49:1062-8.
63. Nguyen-Khac E, Chatelain D, Tramier B, et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: Prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008;28:1188-98.
64. Nitta Y, Kawabe N, Hashimoto S, et al. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatology Res 2009;39:675-84.
65. Nudo CG, Jeffers LJ, Bejarano PA, et al. Correlation of laparoscopic liver biopsy to elasticity measurements (FibroScan) in patients with chronic liver disease. Gastroenterol Hepatol 2008;4:862-70.
66. Obara N, Ueno Y, Fukushima K, et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol 2008;43:720-8.
67. Petta S, Di M, V, Camma C, Butera G, Cabibi D, Craxi A. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: The effects of body mass index. Aliment Pharmacol Ther 2011;33:1350-60.
68. Rifai K, Cornberg J, Mederacke I, et al. Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liv Dis 2011;43:491-7.
69. Sanchez-Conde M, Montes R, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010;17:280-6.
70. Sporea I, Sirli R, Deleanu A, et al. Comparison of the liver stiffness measurement by transient elastography with the liver biopsy. World J Gastroenterol 2008;14:6513-7.
71. Sporea I, Sirli R, Popescu A, Danila M. Acoustic radiation force impulse (ARFI) - a new modality for the evaluation of liver fibrosis. Med Ultrason 2010;12:26-31.
72. Sporea I, Sirli RL, Deleanu A, et al. What did we learn from the first 3,459 cases of liver stiffness measurement by transient elastography (FibroScan)? Ultraschall in der Medizin 2011;32:40-5.
73. Sporea I, Sirli RL, Deleanu A, et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall in der Medizin 2011;32:Suppl 52.
74. Wang JH, Changchien CS, Hung CH, et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol 2009;44:439-46.
75. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010;51:454-62.
76. Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 2010;256:640-7.
77. Yoneda M, Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liv Dis 2008;40:371-8.
78. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.